Table 6.
TF | Number of pathways | Pathways a |
---|---|---|
ATF1 | 7 | ERK/MAPK Signaling, Role of BRCA1 in DNA Damage Response, LPS‐stimulated MAPK Signaling, p38 MAPK Signaling, PI3K Signaling in B Lymphocytes, CD40 Signaling, ATM Signaling |
BACH1 | 1 | NRF2‐mediated Oxidative Stress Response |
ELF1 | 3 | Telomerase Signaling, HGF Signaling, ERK/MAPK Signaling |
ELK1 | 45 | ErbB2‐ErbB3 Signaling, Estrogen‐Dependent Breast Cancer Signaling, Corticotropin Releasing Hormone Signaling, HGF Signaling, Glucocorticoid Receptor Signaling, IL‐2 Signaling, IL‐10 Signaling, ERK/MAPK Signaling, Erythropoietin Signaling, IL‐3 Signaling, LPS‐stimulated MAPK Signaling, Cholecystokinin/Gastrin‐mediated Signaling, p38 MAPK Signaling, PI3K Signaling in B Lymphocytes, Gα12/13 Signaling, HMGB1 Signaling, Oncostatin M Signaling, April Mediated Signaling, B Cell Activating Factor Signaling, B Cell Receptor Signaling, Cardiac Hypertrophy Signaling, EGF Signaling, GM‐CSF Signaling, Toll‐like Receptor Signaling, Regulation of IL‐2 Expression in Activated and Anergic T Lymphocytes, Growth Hormone Signaling, PEDF Signaling, IL‐17 Signaling, FLT3 Signaling in Hematopoietic Progenitor Cells, Neuregulin Signaling, PDGF Signaling, ErbB Signaling, RANK Signaling in Osteoclasts, SAPK/JNK Signaling, IGF‐1 Signaling, T Cell Receptor Signaling, Rac Signaling, Renin‐Angiotensin Signaling, IL‐6 Signaling, GNRH Signaling, 14‐3‐3‐mediated Signaling, Relaxin Signaling, CXCR4 Signaling, Acute Phase Response Signaling, Sertoli Cell‐Sertoli Cell Junction Signaling |
ETS1 | 7 | Telomerase Signaling, HGF Signaling, ERK/MAPK Signaling, Sumoylation Pathway, B Cell Receptor Signaling, GM‐CSF Signaling, Renal Cell Carcinoma Signaling |
GABPA | 1 | Agrin Interactions at Neuromuscular Junction |
HDAC6 | 10 | Telomerase Signaling, Hereditary Breast Cancer Signaling, Huntington's Disease Signaling, Chronic Myeloid Leukemia Signaling, Calcium Signaling, Role of NFAT in Cardiac Hypertrophy, Cell Cycle: G1/S Checkpoint Regulation, Phospholipase C Signaling, Cyclins and Cell Cycle Regulation, Adipogenesis pathway |
HDAC8 | 10 | Telomerase Signaling, Hereditary Breast Cancer Signaling, Huntington's Disease Signaling, Chronic Myeloid Leukemia Signaling, Calcium Signaling, Role of NFAT in Cardiac Hypertrophy, Cell Cycle: G1/S Checkpoint Regulation, Phospholipase C Signaling, Cyclins and Cell Cycle Regulation, Adipogenesis pathway |
JUN | 54 | ErbB2‐ErbB3 Signaling, Estrogen‐Dependent Breast Cancer Signaling, Corticotropin Releasing Hormone Signaling, HGF Signaling, Glucocorticoid Receptor Signaling, PCP pathway, IL‐2 Signaling, IL‐10 Signaling, RAR Activation, NRF2‐mediated Oxidative Stress Response, Erythropoietin Signaling, IL‐3 Signaling, Prolactin Signaling, LPS‐stimulated MAPK Signaling, Huntington's Disease Signaling, Sumoylation Pathway, Cholecystokinin/Gastrin‐mediated Signaling, PI3K Signaling in B Lymphocytes, Gα12/13 Signaling, HMGB1 Signaling, April Mediated Signaling, B Cell Activating Factor Signaling, B Cell Receptor Signaling, Thrombopoietin Signaling, Cardiac Hypertrophy Signaling, EGF Signaling, Agrin Interactions at Neuromuscular Junction, Toll‐like Receptor Signaling, CD40 Signaling, Regulation of IL‐2 Expression in Activated and Anergic T Lymphocytes, ATM Signaling, Renal Cell Carcinoma Signaling, JAK/Stat Signaling, IL‐17 Signaling, PDGF Signaling, PPAR Signaling, ErbB Signaling, RANK Signaling in Osteoclasts, SAPK/JNK Signaling, IGF‐1 Signaling, T Cell Receptor Signaling, Rac Signaling, Renin‐Angiotensin Signaling, IL‐6 Signaling, GNRH Signaling, 14‐3‐3‐mediated Signaling, Aryl Hydrocarbon Receptor Signaling, Th2 Pathway, Relaxin Signaling, CXCR4 Signaling, Acute Phase Response Signaling, Sertoli Cell‐Sertoli Cell Junction Signaling, Role of NFAT in Regulation of the Immune Response, Th1 and Th2 Activation Pathway |
JUNB | 2 | PCP pathway, NRF2‐mediated Oxidative Stress Response |
JUND | 3 | Corticotropin Releasing Hormone Signaling, PCP pathway, NRF2‐mediated Oxidative Stress Response |
MEF2A | 9 | Corticotropin Releasing Hormone Signaling, Cholecystokinin/Gastrin‐mediated Signaling, p38 MAPK Signaling, Gα12/13 Signaling, Calcium Signaling, Role of NFAT in Cardiac Hypertrophy, Cardiac Hypertrophy Signaling, Phospholipase C Signaling, Role of NFAT in Regulation of the Immune Response |
SMARCC1 | 5 | Glucocorticoid Receptor Signaling, Hereditary Breast Cancer Signaling, RAR Activation, Role of BRCA1 in DNA Damage Response, AMPK Signaling |
SMARCC2 | 5 | Glucocorticoid Receptor Signaling, Hereditary Breast Cancer Signaling, RAR Activation, Role of BRCA1 in DNA Damage Response, AMPK Signaling |
SP1 | 9 | Telomerase Signaling, ErbB2‐ErbB3 Signaling, Estrogen‐Dependent Breast Cancer Signaling, IL‐10 Signaling, Prolactin Signaling, Huntington's Disease Signaling, Sumoylation Pathway, HMGB1 Signaling, Aryl Hydrocarbon Receptor Signaling |
STAT5A | 18 | ErbB2‐ErbB3 Signaling, Estrogen‐Dependent Breast Cancer Signaling, Glucocorticoid Receptor Signaling, IL‐2 Signaling, RAR Activation, Erythropoietin Signaling, IL‐3 Signaling, Prolactin Signaling, Chronic Myeloid Leukemia Signaling, Oncostatin M Signaling, Thrombopoietin Signaling, Growth Hormone Signaling, JAK/Stat Signaling, FLT3 Signaling in Hematopoietic Progenitor Cells, Neuregulin Signaling, PPAR Signaling, Th2 Pathway, Th1 and Th2 Activation Pathway |
TCF12 | 1 | PEDF signaling |
Pathways determined to be significantly enriched in TF dataset, with a −log P‐value of >1.3.